An open-label trial of adjunctive galantamine maintenance therapy to treat functional impairments in chronic outpatients with schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 30 Jul 2008
At a glance
- Drugs Galantamine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 30 Jul 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.